BLACK WEEKSVialer −15% · kit −10% · övrigt −5%med kodFri frakt inom Tyskland från €200

Den här sidan har översatts automatiskt och kan innehålla fel. Har du svenska som modersmål? Vi tar gärna emot din feedback och dina förbättringar.Skicka feedback

The Peptide Desk The Peptide Desk
BPC-157 Oral, produktfoto
Healing Oral

BPC-157 Oral

Healing Oral

  • Skickas från Tyskland

Beställning

Styckpris - Fri frakt inom Tyskland från 200 € under Black Weeks
  • DHL med spårning
  • Diskret förpackning

4.6 av 5 på Trustpilot73 omdömen

I korthet

BPC-157 Oral i siffror

Nyckeltalen från vårt lexikon.

Hela lexikonartikeln
Class
Pentadecapeptidehealing, oral
Use
Oraltablet, 500mcg
Sizes
500 mcg1 size in the shop

What studies show

The source in the lexicon
  1. Stable gastric pentadecapeptide BPC 157 and wound healing (review) (opens in a new tab)

    Seiwerth, Sikiric et al., Frontiers in Pharmacology, 2021

Det finns ännu ingen labbanalys för BPC-157 Oral. Rösta på denLåt testa själv, vi betalar halvaAlla labbanalyser

Kunskap

Allt om BPC-157 Oral

FAQ

Vanliga frågor

Källor till varje svar: lexikonartikel

Har du fortfarande en fråga?

Skriv till oss, vårt team hjälper dig.

Is the tablet different from the capsule?

Not in terms of the compound. Tablet and capsule both contain BPC-157, only the dosage form differs. There are no comparative data between the two forms and no published human study of either.

Is BPC-157 absorbed by mouth at all?

According to a review by the developer group, BPC-157 is stable in human gastric juice. In rat studies it worked via the drinking water much like when injected. There are no blood measurements after oral dosing. After dosing into muscle 14 to 19 percent reached the blood in rats and 45 to 51 percent in dogs, the half-life was under 30 minutes.

What do the animal studies show for the gut?

In rats with a fistula between colon and skin the colon and skin defects healed faster when BPC-157 was injected or added to the drinking water. In short bowel syndrome the animals given BPC-157 by mouth or by injection started gaining weight again right away. There are also findings on alcohol and painkiller damage to the stomach and oesophagus.

Are there studies in humans?

Very few. A systematic review up to June 2026 found three studies with 30 people in total: dosing into the knee, into the bladder and a small safety study into a vein. All without a control group, none with a tablet. The registry also lists a phase 1 tablet study from 2015 and a gummy study completed in 2025, both without published results.

Which trials are running right now?

As of 26 October 2026 no trial with BPC-157 is recruiting. A phase 1 trial with 30 planned participants after shoulder surgery has been announced, where BPC-157 is injected under the skin, with the start planned for January 2027. No tablet trial is currently running.

Which side effects are known?

No treatment-related side effects occurred in the three small human studies, but the certainty is very low. One review found no clinical safety data and names risks from unregulated manufacturing and contamination. There are no data of its own on the tablet.

Relaterat

Relaterade produkter